GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we treat diabetes mellitus . These prescription therapies help imitating the body’s inherent GLP-1 https://leftbookmarks.com/story21754057/glp-1-a-major-breakthrough-in-diabetes-treatment